Therefore, this study aimed to determine the relationship between FGF23, traditional markers of CKD-MBD and mortality in patients on dialysis; and tested the hypothesis that high level of plasma FGF23 is expected to be an independent predictor of all -cause mortality in South African patients on maintenance haemodialysis. The gene discussed is FGF23; the disease is Marchiafava-Bignami disease.